Cytori Therapeutics, Inc.

Cytori Receives Cell Banking Patent for the Celution® System

Published in Lab Business Week, March 29th, 2009

Cytori Therapeutics, Inc. (NASDAQ:CYTX) received U.S. Patent No. 7,501,115 (the ‘115 patent), which covers methods of cooling and cryopreserving stem and regenerative cells processed by the Celution® System. This patent provides additional protection for the Company’s cell banking platform, the StemSource® Cell Bank, which Cytori is currently commercializing in both Europe and Asia.

The ‘115 patent protects another specific commercial application of the core Celution® System technology, which is covered under U.S. Patent No. 7,390,484 (the ‘484 patent), issued in July 2008. In addition to the ‘484 patent, the Company now has three patents covering various formulations...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2009-03-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry